These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7684458)

  • 1. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
    Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
    J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
    Anderson S; Momoeda M; Kawase M; Kajigaya S; Young NS
    Virology; 1995 Jan; 206(1):626-32. PubMed ID: 7530397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
    Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
    J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit interaction in B19 parvovirus empty capsids.
    Rosenfeld SJ; Young NS; Alling D; Ayub J; Saxinger C
    Arch Virol; 1994; 136(1-2):9-18. PubMed ID: 7516147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.
    Bloom ME; Martin DA; Oie KL; Huhtanen ME; Costello F; Wolfinbarger JB; Hayes SF; Agbandje-McKenna M
    J Virol; 1997 Jan; 71(1):705-14. PubMed ID: 8985402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
    Gigler A; Dorsch S; Hemauer A; Williams C; Kim S; Young NS; Zolla-Pazner S; Wolf H; Gorny MK; Modrow S
    J Virol; 1999 Mar; 73(3):1974-9. PubMed ID: 9971777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate recombinant vaccine for human B19 parvovirus.
    Bansal GP; Hatfield JA; Dunn FE; Kramer AA; Brady F; Riggin CH; Collett MS; Yoshimoto K; Kajigaya S; Young NS
    J Infect Dis; 1993 May; 167(5):1034-44. PubMed ID: 8486937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.
    Zuffi E; Manaresi E; Gallinella G; Gentilomi GA; Venturoli S; Zerbini M; Musiani M
    Viral Immunol; 2001; 14(2):151-8. PubMed ID: 11398810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.
    Sato H; Hirata J; Furukawa M; Kuroda N; Shiraki H; Maeda Y; Okochi K
    J Virol; 1991 Apr; 65(4):1667-72. PubMed ID: 1705987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
    Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
    Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
    Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
    J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.
    Musiani M; Manaresi E; Gallinella G; Venturoli S; Zuffi E; Zerbini M
    J Med Virol; 2000 Mar; 60(3):347-52. PubMed ID: 10630969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.
    Yoshimoto K; Rosenfeld S; Frickhofen N; Kennedy D; Hills R; Kajigaya S; Young NS
    J Virol; 1991 Dec; 65(12):7056-60. PubMed ID: 1719240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
    Kawase M; Momoeda M; Young NS; Kajigaya S
    Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
    Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
    Corcoran A; Mahon BP; Doyle S
    J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.